Bioactive Compounds Targeting Neurodegenerative Diseases

The term “neurodegenerative disorders” refers to a broad category of pathological ailments that occur from increasing damage to the connections between the nervous system and the neurons. These disorders primarily affect neuronal malfunction and cause issues with strength, mobility, cognition, coordination, and sensation. Because of the body's need for and use of oxygen, the brain is susceptible to a variety of challenges, most notably oxidative stress. Potential neuroprotective drugs for the treatment of neurodegenerative disorders have been identified in natural products. Natural products derived from plants, animals, and fungi as well as the bioactive compounds they contain have been thoroughly investigated and studied in recent years for potential therapeutic uses against a range of disorders, including cancer, diabetes, hypertension, cardiovascular disease, and neurodegenerative diseases. The body's need for and usage of oxygen can lead to oxidative stress, which is one of the stresses that can affect the brain. The brain's high content of unsaturated fatty acids makes it more vulnerable. Crucial goals include addressing oxidative damage and developing effective and safe therapies for neurodegenerative diseases. Research into bioactive chemicals is essential to this endeavor.

The human brain is made up of neurons and neuroglia, the latter of which are essential for maintaining neurons and responding to injury. Brain activity impairment can result from malfunctioning neuroglia. Chronic neuroglial activation affects neurodegeneration, which has a major impact on brain aging and neuropathological diseases. There are intriguing neuroprotective chemicals in traditional medicine that may offer an effective option than synthetic drugs. Researchers can improve natural treatments for neurological disorders by isolating active phytochemicals while discovering more about their processes, doses, and safety profiles. A variety of food sources including marine algae have neuroprotective properties. Bioactive substances with anti-inflammatory and antioxidant properties are found in marine algae. Nuts, fruits, vegetables, and other foods include phytochemicals that can prevent neurodegeneration. Resveratrol, curcumin, sulforaphane, flavonoids, and organosulfur compounds are important substances that shield neurons by a variety of mechanisms, such as anti-inflammatory and antioxidant ones. In addition to supporting general brain health, a varied diet high in these neuroprotective chemicals may lower the risk of neurological disorders.

Neurodegenerative Disorders (NDs) are caused by a major loss of neurons both structurally and functionally. The current method of disease management has now encountered several side effects and also the progressive nature of NDs always evokes patients to switch to other drugs. The helpful impact of medicinal plants in these situations has been attributed to their demonstration through several cellular and molecular processes. Natural phytochemicals have served as a good and reliable resource for disease treatment and management. A few neuroprotective mechanisms of these phytochemicals include the reduction in inflammatory responses, the inhibition of pro-inflammatory cytokines' functional aspects, such as tumor growth, and the enhancement of antioxidant qualities. Prevention strategies of these phytoconstituents for NDs heavily rely on variations in transcription and transduction pathways. Aging is one of the main causes of NDs and disease progression, which are mostly brought on by protein loss, oxidative and inflammatory stress, environmental changes, and other factors. Neurodegenerative disorders can be treated with natural substances. Some of the therapeutic herbs for preventing NDs are ginseng, Withania somnifera, Bacopa monnieri, ginkgo biloba, and others.

The Blood-Brain Barrier (BBB) limits the ability of therapeutic molecules to reach the brain following oral or parenteral administration. The nasal delivery system has the potential to be used for drug delivery due to its ease of administration and increased bioavailability. This approach to brain targeting has shown great promise and is useful in treating a range of illnesses linked to dysfunctional brain function. This, along with drug elimination and inactivation during the drug's journey in the systemic circulation and hepatic metabolism, reduces the effectiveness of treatment, necessitates high drug dosages, and frequently results in unfavorable side effects. The anatomical benefits of the nasal route, which allow for the direct delivery of drugs from the nasal cavity to the brain and avoid the blood-brain barrier, are the driving force behind this developing discipline. In addition to playing a significant role in the pathophysiology of neurodegenerative illnesses, oxidative stress can also play a significant role in the damage caused by cerebral ischemia and apoptosis. An interesting new development in medicine is the fascinating intersection of medicinal plants, their bioactive constituents, and nanotechnology, which has shown promise in the treatment of various NDDs. Drug concentration in the brain is increased through nose-to-brain delivery, which circumvents the blood-brain barrier and permits the direct movement of therapeutic molecules. 

The Blood-Brain Barrier (BBB) is a highly selective semipermeable membrane that separates the circulating blood from the brain's extracellular fluid, ensuring CNS homeostasis and protecting the brain from harmful substances while allowing essential nutrients to pass. The BBB, composed of specialized endothelial cells connected by tight junctions, poses a significant challenge for drug delivery to the brain due to its restrictive nature. With the help of nanotechnology and the special qualities of nanomaterials such as their tiny size, biocompatibility, and capacity to increase blood circulation promising solutions to these problems remain. The structure and function of the Blood-Brain Barrier (BBB), the potential of nanotechnology for delivering drugs to the brain, and the application of different nanomaterials, such as polymeric, liposomal, dendrimer, and inorganic nanoparticles, in the treatment of neurological disorders are all covered in this study. Also, the neurotoxicity of nanomaterials and the therapeutic and neuroprotective potential of phytoconstituents are explained. 

The Central Nervous System (CNS) plays a pivotal role in regulating essential physiological processes, highlighting the critical need for effective therapeutic interventions targeting CNS disorders. Bioactive compounds, including small molecules and peptides, offer promising avenues for CNS drug discovery and development by modulating specific molecular targets implicated in neurological pathophysiology. However, the Blood-Brain Barrier (BBB) poses a formidable obstacle to CNS drug delivery, necessitating innovative approaches such as nanoparticle delivery systems, viral vectors, and alternative delivery methods like convectionenhanced delivery. This chapter comprehensively explores clinical strategies, management approaches, and challenges associated with targeting the CNS through bioactive compounds. It examines pharmacokinetic and pharmacodynamic considerations relevant to CNS drug delivery, highlighting innovative technologies and formulation approaches aimed at enhancing therapeutic efficacy. Despite significant progress, formidable challenges persist, including the complexity of CNS biology, the risk of off-target effects, and stringent regulatory requirements. Future research directions encompass developing better preclinical models, exploring multi-target approaches, and implementing early intervention strategies supported by advanced biomarkers to address the global burden of neurological disorders effectively.

Neurodegenerative disorders, including Alzheimer's, Parkinson's, Huntington's, and Amyotrophic Lateral Sclerosis (ALS), pose significant challenges due to their progressive nature and debilitating effects on patients' quality of life. Recent advancements in biomedical research have spurred the development of novel therapeutic strategies aimed at modifying disease progression and improving patient outcomes. These strategies encompass a wide array of approaches such as small molecule drugs, biologics, brain and physical exercises, gene therapy, AI-based diagnosis and treatment, nano-bioactive approaches, and innovative drug delivery systems designed to enhance Central Nervous System (CNS) penetration and target specific pathological mechanisms. Despite these promising developments, the complexity of neurodegenerative diseases necessitates multifaceted treatment paradigms that combine neuroprotection, neuronal restoration, and symptomatic management. However, several challenges persist. The Blood-Brain Barrier (BBB) remains a significant obstacle to effective drug delivery, while the heterogeneous nature of these diseases requires personalized treatment approaches. Also, safety and management of the side effects of advanced therapies such as gene therapy and brain stimulation techniques are critical concerns. The Intellectual Property (IP) landscape further complicates the development of new treatments. Navigating this complex terrain involves dealing with overlapping patents, the expiration of early patents leading to increased competition, and the high costs associated with bringing new therapies to market. Ethical and legal considerations, particularly concerning advanced technologies, add another layer of complexity.